AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Superficial Radiation Therapy: Pros, Cons, and Appropriate Use

Description

Dr. Henry Heaton discusses the role of superficial radiation therapy (SRT) in treating skin cancer, highlighting its workings, advantages, downsides, and optimal patient demographics. SRT employs low-energy ionizing radiation, primarily targeting rapidly dividing cancer cells while minimizing harm to healthy tissue through techniques like fractionation. He discusses various SRT protocols, noting that while hypofractionated regimens are more convenient, they may compromise long-term cosmetic outcomes. Cure rates for SRT are variable but can be comparable to surgical options for certain skin cancers, particularly basal cell carcinoma. However, surgical methods like Mohs micrographic surgery generally yield better long-term results. Patient experience during SRT is favorable, with lower morbidity compared to surgery, though there is a risk of delayed wound breakdown. Cosmetic changes may include skin atrophy and pigmentation alterations, with SRT being recommended for older patients with small, low-grade tumors on less complex areas, considering the risks of secondary malignancy from radiation. He emphasizes careful selection of candidates for SRT and the importance of informed patient consent regarding treatment options. Dr. Heaton calls for the dermatology community to create guidelines for appropriate SRT use, benefiting from the insights of experienced clinicians to navigate its rising popularity driven by commercial interests.

View more

Conclusions

  • Superficial Radiation Therapy (SRT) can be a viable treatment option for non-melanoma skin cancers, particularly in elderly patients with low-grade tumors.
  • SRT offers cure rates that can be comparable to traditional surgical methods when appropriately selected for specific tumor types and locations.
  • The effectiveness of SRT is influenced by factors such as tumor size, location, and histology, with superficial basal cell carcinomas and in situ squamous cell carcinomas responding best.
  • Patients undergoing SRT generally experience less pain and shorter recovery times compared to surgical interventions.
  • While acute side effects like mild radiation dermatitis are common, severe reactions are rare with proper precautions and monitoring.
  • SRT-associated cosmetic outcomes can be initially favorable but may deteriorate over time, contrasting with surgical scars that may improve or stabilize.
  • Risks associated with SRT include an increased likelihood of secondary malignancies, particularly for younger patients, necessitating careful patient selection and counseling.
  • The study emphasizes the need for standardized training and guidelines in the use of SRT among dermatology practitioners to ensure appropriate treatment recommendations.
  • Cognetta AB, Wolfe CM, Goldberg DJ, Hong HG. Practice and Educational Gaps in Radiation Therapy in Dermatology. Dermatol Clin. 2016;34:319-333.
  • Wolfe CM, Cognetta AB. Radiation therapy (RT) for nonmelanoma skin cancer (NMSC), a cost comparison: Clarifying misconceptions. J Am Acad Dermatol. 2016;75(1):654-655.
  • Grossi Marconi D, da Costa Resende B, Rauber E, et al. Head and neck non-melanoma skin cancer treated by superficial x-ray therapy: an analysis of 1021 cases. Li JJ, ed. PLoS ONE. 2016;11(7):e0156544. doi:10.1371/journal.pone.0156544.
  • Nestor MS, Berman B, Goldberg D, Cognetta AB et al. Consensus guidelines on the use of superficial radiation therapy for treating nonmelanoma skin cancers and keloids. J Clin Aesthet Dermatol. 2019;12:12-17.
  • Madorsky SJ, Meltzer OA, Miller A. Superficial Radiotherapy: Long Term Follow-Up of Highly Selected Basal and Squamous Cell Carcinomas in Skin Cancer Patients. J Dermatol & Skin Sci. 2022;4(4):1-5.
  • Cognetta AB, Howard BM, Heaton HP et al. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol. 2012;67(6):1235-1241.
  • Pampena R, Palmieri T, Kyrgidis A, et al. Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): Comparison between 2 different schedules. J Am Acad Dermatol. 2016;74(2):341-347.
  • Cho M, Gordon L, Rembielak A, Woo TCS. Utility of radiotherapy for treatment of basal cell carcinoma: a review. Br J Dermatol. 2014;171(5):968-973.
  • Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23(16):3733-41.
  • Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2012;104(16):1240-50.
  • Thorsness SL, Freites-Martinez A, Marchetta MA, Navarrete-Dehcent C, Lacouture ME, Tonorezos ES. Nonmelanoma skin cancer in childhood and young adult cancer survivors previously treated with radiotherapy. J Natl Compr Canc Netw. 2019;17(3):237-43.
  • Ashack KA, Kuritza V, Visconti MJ, Ashack L. Dermatologic Sequelae Associated with Radiation Therapy. Am J Clin Dermatol. 2020 Aug;21(4):541-555. doi: 10.1007/s40257-020-00519-x. PMID: 32410134.